Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum.

Biomarker Insights
D G WeberM Gube

Abstract

The purpose of this analysis was to evaluate if serum levels of potential tumor markers for the diagnosis of malignant mesothelioma and lung cancer are affected by confounding factors in a surveillance cohort of workers formerly exposed to asbestos. SMRP, CA125, and CYFRA21-1 concentrations were determined in about 1,700 serum samples from 627 workers formerly exposed to asbestos. The impact of factors that could modify the concentrations of the tumor markers was examined with linear mixed models. SMRP values increased with age 1.02-fold (95% CI 1.01-1.03) and serum creatinine concentration 1.32-fold (95% CI 1.20-1.45). Levels differed by study centers and were higher after 40 years of asbestos exposure. CA125 levels increased with longer storage of the samples. CYFRA21-1 values correlated with age 1.02-fold (95% CI 1.01-1.02), serum creatinine 1.21-fold (95% CI 1.14-1.30) and varied by study centers due to differences in sample handling. Tumor marker concentrations are influenced by subject-related factors, sample handling, and storage. These factors need to be taken into account in screening routine.

References

Oct 1, 1983·British Journal of Diseases of the Chest·G Hillerdal
Feb 23, 1999·British Journal of Cancer·J PetoE Negri
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicholas J VogelzangPaolo Paoletti
Nov 25, 2003·Lancet·Bruce W S RobinsonIngegerd Hellstrom
Aug 26, 2004·Clinical Chemistry and Laboratory Medicine : CCLM·Callum G Fraser
Feb 10, 2007·Clinical Chemistry·Heather L BeyerNiranjan Y Sardesai
May 9, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·Francesca Di SerioRaffaele Molinini
May 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bogdan-Dragos GrigoriuPhilippe Lassalle
May 31, 2007·Current Opinion in Pulmonary Medicine·Arnaud Scherpereel, Y C Gary Lee
Jul 25, 2007·Chest·Jenette CreaneyBruce W S Robinson
Sep 6, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alfonso CristaudoRiccardo Puntoni
Sep 14, 2007·Scandinavian Journal of Clinical and Laboratory Investigation·Y-C GaoH-K Lu
Dec 1, 2007·Cancer Biomarkers : Section a of Disease Markers·Daniel G WeberGeorg Johnen
Dec 7, 2007·PloS One·Jason D ThorpeNicole Urban
Dec 25, 2007·The Annals of Thoracic Surgery·Harvey I PassJeffrey Allard
Feb 19, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Oluf Dimitri RoeKristina Kjaerheim
Jun 28, 2008·American Journal of Respiratory and Critical Care Medicine·Eun-Kee ParkAnthony R Johnson
Sep 5, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kimberly A LoweCharles W Drescher
Feb 5, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·José A Rodríguez PortalPilar Cebollero Rivas
May 2, 2009·Clinical Chemistry·Kevin HollevoetJoris R Delanghe

❮ Previous
Next ❯

Citations

Feb 21, 2013·International Archives of Occupational and Environmental Health·Michael K FeltenThomas Kraus
Jan 2, 2013·Medical Oncology·Rosa FilibertiFabio Spigno
Mar 2, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Kevin HollevoetJan P van Meerbeeck
Mar 6, 2012·Clinical Lung Cancer·Kevin HollevoetJoris R Delanghe
Sep 7, 2012·Safety and Health at Work·Eun-Kee ParkAnthony R Johnson
Sep 17, 2016·Cancer Biomarkers : Section a of Disease Markers·Juan WangGuixiang Tai
Dec 15, 2010·Biomarker Insights·Marc A Williams
Oct 25, 2012·Clinical Chemistry and Laboratory Medicine : CCLM·Eun-Kee ParkDeborah H Yates

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
blood drawing

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.